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Evaluation of the Benefits
and Risks of Introducing
Ebola Community Care Centers,
Sierra Leone
Adam J. Kucharski, Anton Camacho, Francesco Checchi, Ron Waldman,
Rebecca F. Grais, Jean-Clement Cabrol, Sylvie Briand, Marc Baguelin,
Stefan Flasche, Sebastian Funk, W. John Edmunds

In some parts of western Africa, Ebola treatment centers
(ETCs) have reached capacity. Unless capacity is rapidly
scaled up, the chance to avoid a generalized Ebola epidemic will soon diminish. The World Health Organization
and partners are considering additional Ebola patient care
options, including community care centers (CCCs), small,
lightly staffed units that could be used to isolate patients outside the home and get them into care sooner than otherwise
possible. Using a transmission model, we evaluated the
benefits and risks of introducing CCCs into Sierra Leone’s
Western Area, where most ETCs are at capacity. We found
that use of CCCs could lead to a decline in cases, even if
virus transmission occurs between CCC patients and the
community. However, to prevent CCC amplification of the
epidemic, the risk of Ebola virus–negative persons being exposed to virus within CCCs would have to be offset by a reduction in community transmission resulting from CCC use.

T

he current epidemic of Ebola virus disease in western
Africa has resulted in thousands of cases during 2014
(1). To date, Ebola treatment centers (ETCs) have been used
to isolate patients and provide clinical care. These facilities
typically have large capacity (some have >100 beds) and
function under high levels of infection control. However,
in Sierra Leone, ETCs have reached capacity, and patients
are being turned away (1). The reproduction number (defined as the average number of secondary cases generated
by a typical infectious person) has been >1 in Sierra Leone,
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leading to growth in the number of cases reported each
week (2–4). As a result, there is an urgent need to rapidly
scale up treatment and isolation facilities. Delays in implementation will result in falling further behind the epidemic
curve and in an even greater need for patient care facilities.
ETCs are complex facilities that require a substantial
number of staff and time to set up; thus, the World Health
Organization and other partners are looking at additional
care options to supplement existing ETCs. One approach
is the use of Ebola community care centers (CCCs), which
would represent a possible change in operational approach
(5–7). As envisioned in the World Health Organization
approach, CCCs would be small units with 3–5 beds and
would be staffed by a small group of health care workers.
The main objective would be to isolate patients outside the
home and, hence, reduce the movement and contacts of infectious persons within the community. CCCs are designed
to engage the community and to increase the acceptance
of isolation. Care for patients in CCCs would be provided
primarily by a caregiver who would be given personal protective equipment (PPE) and basic patient care training.
Patients would be free to leave the unit while awaiting test
results. The specific utilization of CCCs would vary, depending on local context, and units would form part of a
package of interventions, including monitoring of community contacts and burials within the community.
CCCs would be easier to set up than ETCs because
they would be lightly staffed and could be made from local
materials or even tents. Thus, CCCs have the potential to
more rapidly begin treating patients. At present in Sierra
Leone, the average time from symptom onset to hospitalization for Ebola virus disease patients is 4.6 days, which
means patients remain in the community until the late stage
of the disease (4). However, the use of CCCs has potential
risks: the number of cases could be amplified if Ebola virus–negative patients in CCC assessment areas are exposed
to infectious persons before admission, and virus could be
transmitted between patients and caregivers or others in
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the community if virus containment within the CCC is not
perfect. Given the urgent need for new operational solutions for Ebola patient care, it is critical to assess the conditions under which CCCs might exacerbate or mitigate the
epidemic and to compare the scale-up of CCCs with the
expansion of ETCs or home care.
We used an Ebola virus transmission model to evaluate the relative benefits and risks of introducing CCCs in a
situation similar to that in Western Area, an administrative
division of Sierra Leone. Western Area has exhibited consistent exponential growth in reported cases, and ETCs in
the area are at capacity (1). Expert elicitation was used to
estimate plausible values for key model parameters; these
values were compared with simulation results to establish
whether CCCs could be beneficial. We also estimated how
many CCC beds, either alone or in combination with additional ETC beds, would be required to potentially turn over
the epidemic (i.e., reduce the reproduction number below
the critical threshold of 1).
Methods
Because precise medical and operational details of CCCs
are still under discussion, we focused on the implications
of CCC introduction under a set of general assumptions.
We modeled Ebola transmission by using a modified susceptible-exposed-infectious-resolved framework (8–10). In
the model, persons were initially susceptible to the virus;
upon infection, patients moved into a latent state for an average of 9.4 days (4) and then became symptomatic and
infectious for an average of 9.5 days (4) before the disease
was resolved (through either recovery or death and burial) and the patient no longer contributed to transmission.
The model accounted for changes in ETC capacity to date
(details available at https://drive.google.com/file/d/0B_
BzCqSK1DZaYnRoeWtHOTU2TVk/).
First, we used the model to generate epidemiologic
forecasts for Western Area and to establish a baseline scenario for the level of infection if no additional interventions were introduced. We fitted the model to the number
of weekly reported Ebola virus disease cases in Western
Area during August 16–November 31, 2014 (1). We estimated that in Western Area the basic reproduction number (defined as the average number of secondary cases
generated by a typical infectious person in the absence of
control measures) was 1.94 (95% credible interval [CrI]
1.86–1.98) and that there would be 1,060 exposed persons
(95% CrI 800–1,420) and 650 symptomatic persons (95%
CrI 460–910) in the community on December 1, 2014.
To model the introduction of CCCs, we assumed that
Ebola virus–susceptible persons could also become infected
with other febrile diseases that have Ebola virus disease–like
symptoms, which we assumed had symptoms that lasted an
average of 7 days. Thus, 2 types of symptomatic persons were
394

included in our simulation model: Ebola virus–positive and
Ebola virus–negative patients (Figure 1; https://drive.google.
com/file/d/0B_BzCqSK1DZaYnRoeWtHOTU2TVk/).
In the model, Ebola virus–positive and –negative patients
took an average of 4.6 days (4) after the onset of symptoms
before attending an ETC. The probability that a patient
was admitted to an ETC depended on the number of currently available beds. Well-managed ETCs operate strict
patient isolation, careful use of PPE, and safe burial procedures (11,12), so we assumed that no virus transmission
occurred between Ebola virus–infected patients and community members once patients were admitted to an ETC. If
suspected case-patients were admitted to ETCs and subsequently found to be negative for Ebola virus, they returned
to the community; we assumed there was no risk of Ebola
virus–negative patients becoming infected while waiting for
test results.
We also included CCCs in the model. We assumed that
for patients visiting local CCCs, the time between symptom
onset and CCC visit was shorter than that for patients visiting the larger and more distant ETCs; in the main analysis,
we assumed that the average time from symptom onset to
CCC attendance was 3 days. If CCCs were full, then patients attended ETCs instead. If ETCs were full, patients remained in the community. We assumed there was a possibility for some transmission of virus from CCC patients to
community members (either directly, through caregivers,

Figure 1. Structure of transmission model used to evaluate the
benefits and risks of introducing CCCs into Western Area, Sierra
Leone. Persons start off being susceptible to infection (S). Upon
infection with Ebola virus, they enter an incubation period (E),
and at symptom onset, they become infectious in the community
(I+). After this point, infected persons seek health care in CCCs
or ETCs; if centers are full, the infectious persons remain in the
community until the infection is resolved (R) (i.e., the patients
have recovered from the disease or are dead and buried).
Patients admitted to ETCs and CCCs also move into the resolved
compartment (R). We also assume that Ebola virus–susceptible
persons could also become infected with other febrile diseases
that have Ebola virus disease–like symptoms (I–). These Ebola
virus–negative patients also seek health care; if centers are
full, the patients return to the susceptible compartment (S) as
symptoms wane. We assume the latent period is 9.4 days, the
average time from symptom onset to CCC attendance is 3 days,
and the average interval from symptom onset to ETC attendance
is 4.6 days. CCCs, Ebola community care centers; ETCs, Ebola
treatment centers.
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or during burial); we did not assume any transmission of
virus from ETC patients. There was also a chance that
Ebola virus–negative patients would be exposed to Ebola
virus while waiting for test results. We assumed that 50%
of symptomatic patients who attended CCCs/ETCs were
Ebola virus–positive; on the basis of the number of Ebola
virus disease cases and noncases reported in Sierra Leone,
this percentage is plausible (1,13,14).
Two other parameters, besides the shorter time between onset of symptoms and attendance at a center, make
CCCs potentially different from ETCs in the model: 1) the
probability that Ebola virus–negative patients would be exposed to Ebola virus while waiting for test results in CCCs
and 2) the reduction in virus transmission from infectious
patients to the community as a result of the patient being
isolated in a CCC. If the CCC model had a 100% reduction
in transmission and 0% chance that Ebola virus–negative
patients would be exposed virus, it was equivalent to the
ETC set-up in the model, except that there would be a reduced time from symptom onset to CCC attendance.
Results
We first considered the potential level of infection in the community during December 2014 based on our estimates for
Western Area. With 259 ETC beds available (1,14–16), our
model suggests that ETCs would be at capacity in mid-December and the number of cases would rise over the following weeks (Figure 2, panel A). We also considered the possibility that a proposed additional 500 ETC beds (15) would
be introduced on December 15, 2014 (Figure 2, panel B). Our
forecast suggested that the addition of these beds would cause
the growth in number of cases to slow in the following weeks,
but the change would not turn over the epidemic.
To assess what reduction in transmission and in risk
of Ebola virus–negative patient exposure to virus would be
required for 500 CCC beds to be beneficial, we varied 2
key parameters and, after 30 days, compared model outputs with those for the baseline scenario (Figure 3, panel
A). If there is a high probability that Ebola virus–negative
patients will be exposed but only a small reduction in transmission, CCCs could act as incubators and generate more
cases than the baseline scenario with 259 ETC beds only.
The CCC approach has not been fully tested in the field,
so we conducted an elicitation of 6 expert opinions to obtain estimates for the median and interquartile range (IQR)
for reduction in transmission as a result of patients being
in CCCs and for the probability of exposing Ebola virus–
negative patients to infectious patients (details at https://
drive.google.com/file/d/0B_BzCqSK1DZaYnRoeWtHOTU2TVk/). The distribution for the group opinion for
reduction in transmission while in a CCC had a median of
63% (IQR 41%–81%). The distribution for the probability of exposure had a median of 0.09 (IQR 0.01–0.36).

When compared with model results, these estimates were
within the region of parameter space in which CCCs would
be beneficial (see Figure 3 at https://drive.google.com/file/
d/0B_BzCqSK1DZaYnRoeWtHOTU2TVk/).

Figure 2. Model fits and forecasts used to evaluate the benefits
and risks of introducing Ebola community care centers into
Western Area, Sierra Leone. A) Reported cases over time.
Black points show reported incidence data. B) No. patients in
ETC beds. Blue lines to the left of the dashed vertical divides
show the median estimate; blues line to the right of the dashed
vertical divides show forecast with no change in number of
ETC beds; green lines show forecast if 500 ETC beds are
introduced on December 15, 2014. Shaded areas represent
95% credible interval, which reflects uncertainty about reporting
and model parameters; darker shading indicates overlap
between 2 forecasts. Estimates were scaled depending on the
number of daily situation reports issued by the Sierra Leone
Ministry of Health and Sanitation each week (see https://drive.
google.com/file/d/0B_BzCqSK1DZaYnRoeWtHOTU2TVk/).
ETC, Ebola treatment center.
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To confirm that 63% was a plausible value for reduction
in transmission, we used the following theoretical argument.
In the model, the basic reproduction number, R0, was near 2,
the time from onset to outcome was 9.5 days on average, and
patients took an average of 3 days after onset of symptoms
to attend CCCs. If infected persons did not enter an available
CCC and instead remained in the community for the next
6.5 days, they would generate an average of 1.4 secondary
cases (because 2 × 6.5/9.5 = 1.4). Even if Ebola patients had
a 50% probability of infecting their sole caregiver, it meant
they would, on average, generate 0.5 secondary cases while
in a CCC. The relative reduction in cases as a result of being
in a CCC would therefore be (1.4 –0.5)/1.4 = 64%. If each
case-patient generated an average of 0.25 cases while in a
CCC, the expected reduction would be ≈80%.
To elucidate the potential benefits and risks of CCC
introduction, we considered 2 specific examples. If CCCs
reduced virus transmission from Ebola virus–infected patients to the community by 75% once the patient was admitted and if Ebola virus–negative patients have a 25%
probability of exposure while waiting for test results, then
the introduction of 500 CCC beds would slow virus transmission (Figure 3, panel B). However, if CCCs only reduced transmission by 25% and Ebola virus–negative patients have a 50% probability of exposure to Ebola virus,
the introduction of 500 CCC beds could lead to a rise in the
number of cases within the community (Figure 3, panel B).
We also assessed how many CCC beds would be required to stop the exponential increase in cases and turn
over the epidemic (i.e., reduce the reproduction number
of the infection, R, to <1). A larger number of beds would
be required if the reduction in transmission was smaller
(Figure 4, panel A). The requirement was also larger if Ebola virus–negative patients were more likely to be exposed
to virus, patients took longer to attend CCCs, or there were
more Ebola virus–negative patients (see figures 4 and 5 at
https://drive.google.com/file/d/0B_BzCqSK1DZaYnRoe
WtHOTU2TVk/). The large number of infected persons on
December 1, 2014, meant that the number of cases still rose
in the model (Figure 2), suggesting additional interventions
would be required to control the epidemic. Therefore we assessed a combination of the 2 health care approaches, with
additional ETC beds, CCC beds, or both introduced on December 15, 2014 (Figure 4, panel B). Because CCCs reduce
the time from symptom onset to attendance at a health care
center, our results suggest it would be possible to turn over
the epidemic in Western Area with a sufficient number of
CCC beds, either as a standalone strategy or in combination
with additional ETCs.
Discussion
We used a transmission model to evaluate the potential effects of the introduction of Ebola CCCs in Western Area,
396

Figure 3. Factors influencing reduction or amplification of Ebola
virus infection in the community if 500 CCC beds were introduced
in Western Area, Sierra Leone, on December 15, 2014. A) Change
in infection compared with baseline scenario (259 Ebola treatment
center beds) between December 1, 2014, and February 1, 2015,
for a range of values for reduction in transmission and probability
of exposure to virus. Median parameter estimates for Western
Area were used (Table). B) Change in infection over time. Black
line, baseline scenario. Blue line, 500 CCC beds with transmission
reduced by 75% (blue line in A), and Ebola virus–negative patients
have 25% probability of exposure to virus. Red line, 500 CCC
beds with transmission reduced by 25% (red line in A), and Ebola
virus–negative patients have 50% probability of exposure to virus.
Shaded areas show 95% bootstrapped credible intervals generated
from 1,000 simulations with parameters sampled from posterior
estimates. We assumed that time from symptom onset to CCC
attendance was 3 days and that 50% of symptomatic patients were
Ebola virus–positive. CCC, Ebola community care center.
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Table. Parameters used in a transmission model for evaluating the benefits and risks of introducing CCCs into Western Area,
Sierra Leone*
Parameter
Value
Source
Mean time from symptom onset to outcome
Ebola virus–positive patients
9.5 d
(4)
Ebola virus–negative patients
7.0 d
Assumed
Mean time from symptom onset to admission
To ETC
4.6 d
(4)
To CCC
3.0 d
Assumed
Mean time from exposure to symptom onset (latent period)
9.4 d
(4)
Proportion of patients with Ebola-like symptoms in Western Area who are Ebola-positive
50.0%
(1)
Population of Western Area
1.4 million
(17)
Probability that an Ebola virus–negative patient seeking care in CCC will be exposed to Ebola
Varies†
NA
virus
Reduction in transmission from infected patients to the community as a result of being in CCC
Varies†
NA
Basic reproduction no. (95% CrI)‡
1.94 (1.86–1.98)
Estimated
No. infectious persons on August 16, 2014 (95% CrI)§
51 (39.0–57.0)
Estimated
Proportion of cases in Western Area reported in Sierra Leone Ministry of Health situation reports
0.42 (0.33–0.46)
Estimated
(95% CrI)
Variability in accuracy of reports, define as standard deviation of proportion of cases reported
0.014 (0.010–0.024)
Estimated
(95% CrI)

*CCC, Ebola community care center; CrI, credible interval; ETC, Ebola treatment center; NA, not applicable.
†In the analysis, the full range of possible values for these parameters is tested.
‡Basic reproduction number refers to the average number of secondary cases generated by a typical infectious patient at the start of an epidemic
§This parameter represents the initial no. of infectious patients at the start of the model simulation. Additional information is available at
https://drive.google.com/file/d/0B_BzCqSK1DZaYnRoeWtHOTU2TVk/.

Sierra Leone. Our results show that CCCs could reduce the
number of Ebola virus disease cases in the community if
1) the probability for Ebola virus–negative patients being
exposed to the virus is low and 2) there is reduction in virus
transmission as a result of infected patients being in CCCs.
The introduction of CCCs could potentially turn over the
epidemic (i.e., reduce the reproduction number, R, below
the critical threshold of 1) if the time from symptom onset
to CCC attendance is <3 days. Assuming that CCCs open
in mid-December, ensuring epidemic turnover would require a large number of CCC beds (potentially at least 500
for Western Area). In addition to reducing the time from
symptom onset to attendance at a treatment facility, a large
number of CCCs would have the added benefit of reducing the time from symptom onset to admission because
infected patients would not have to wait for ETC beds to
become available.
Our analysis does have limitations. One of those limitations is that we used an illustrative scenario for Western
Area based on current epidemiologic reports. Given uncertainty about the influence of factors such as changes in
behavior (18), we focused our analysis on short-term forecasts and estimation of the number of beds required to turn
over the epidemic. However, the epidemiologic landscape
is changing rapidly, and the situation might have been different by late December/January, which would influence
our specific estimates for bed requirements. In addition,
transmission dynamics may vary by district, which would
influence the precise number of beds required in different
areas. Our results should therefore be viewed as qualitative rather than quantitative. In addition, the reduction in
transmission as a result of patients being in CCCs will, in

reality, depend on several factors, including patient movements, PPE effectiveness, infection control in the facility,
and burial procedures (12), and these factors will likely
differ between settings. Because it was not possible to establish the contribution of each factor to disease transmission without detailed data on the source of infection (8), we
used a single parameter to capture the reduction in transmission as a result of a patient being in a CCC. Given the
uncertainty about the precise magnitude of this reduction,
we assessed the effect of CCCs under the full range of potential reductions in transmission, from no change to full
containment, and conducted an elicitation of expert opinions to identify plausible parameter ranges.
Furthermore, we assumed that infectiousness does not
vary over the course of Ebola virus infection. However, if
patients are most infectiousness during the final stages of infection (19,20), then CCCs and ETCs would provide an even
greater reduction in transmission because they would isolate
patients when they are most infectious. In addition, it has
been shown that it is not possible to reliably estimate multiple routes of transmission for Ebola virus from a single incidence curve (8); thus, we chose to model community transmission by using a single parameter, rather than attempting
to estimate the contribution from living infected persons and
from funerals. In the model, we also assumed that all patients
seek health care. If in reality some do not, this will have the
effect of increasing the average time from symptom onset to
admission in a care center. A crucial point is that if patients
on average spent more than half of their infectious periods in
the community, then expansion of bed capacity alone would
not be enough to turn over the epidemic in regions where the
reproduction number is near 2.
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In summary, CCCs may offer a rapid, high-coverage
complement to ETCs and, thus, hold considerable potential
for bringing about a sizeable shift in the epidemic pattern
in Sierra Leone. The UK government is therefore supporting such a combined intervention in the Sierra Leone (7).
However, the CCC approach is little tested in the field and
could be harmful if infection control in CCCs is worse than
that in the community or if Ebola virus–negative patients

have a high risk of exposure to virus. Settings with limited
triage, such as primary health care facilities, may also expose Ebola virus–negative patients to the virus and could
therefore also have the potential to amplify the Ebola epidemic. Given the potential benefits and risks of introducing
CCCs, real-time evaluation of their effectiveness must be
carried out as they are implemented. In particular, to confirm the usefulness of CCCs as an epidemic control strategy, estimates must be determined for the reduction in virus
transmission as a result of infected patients being isolated
in CCCs and for the probability of Ebola virus–negative
patients being exposed to virus in CCCs.
Funding was provided by the Medical Research Council (fellowships: MR/J01432X/1 to A.C., MR/K021524/1 to A.J.K., and
MR/K021680/1 to S.F.) and the Research for Health in Humanitarian Crises (R2HC) Programme, managed by the Research for
Humanitarian Assistance (grant no. 13165).
Dr. Kucharski is a research fellow in infectious disease epidemiology at London School of Hygiene and Tropical Medicine. His research focuses on the dynamics of emerging infections and how population structure and social behavior shape
disease transmission.
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